Richard Vosser
Stock Analyst at JP Morgan
(2.02)
# 3,054
Out of 5,132 analysts
16
Total ratings
66.67%
Success rate
1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Richard Vosser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MOLN Molecular Partners AG | Maintains: Neutral | $4 → $3.75 | $4.65 | -19.35% | 3 | Dec 8, 2025 | |
| GRFS Grifols | Maintains: Neutral | $10 | $9.28 | +7.76% | 1 | Dec 8, 2025 | |
| SNY Sanofi | Downgrades: Neutral | n/a | $47.03 | - | 4 | Dec 8, 2025 | |
| NVS Novartis AG | Upgrades: Overweight | n/a | $161.18 | - | 1 | Dec 8, 2025 | |
| NVO Novo Nordisk | Upgrades: Overweight | n/a | $48.93 | - | 7 | Jun 7, 2022 |
Molecular Partners AG
Dec 8, 2025
Maintains: Neutral
Price Target: $4 → $3.75
Current: $4.65
Upside: -19.35%
Grifols
Dec 8, 2025
Maintains: Neutral
Price Target: $10
Current: $9.28
Upside: +7.76%
Sanofi
Dec 8, 2025
Downgrades: Neutral
Price Target: n/a
Current: $47.03
Upside: -
Novartis AG
Dec 8, 2025
Upgrades: Overweight
Price Target: n/a
Current: $161.18
Upside: -
Novo Nordisk
Jun 7, 2022
Upgrades: Overweight
Price Target: n/a
Current: $48.93
Upside: -